IQVIA Holdings Inc. – NYSE:IQV
IQVIA Holdings stock price today
$191.44
-7.94
-3.99%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 13 hours
IQVIA Holdings stock price monthly change
-11.05%
month
IQVIA Holdings stock price quarterly change
-11.05%
quarter
IQVIA Holdings stock price yearly change
-14.03%
year
IQVIA Holdings key metrics
Market Cap | 35.86B |
Enterprise value | 48.87B |
P/E | 35.16 |
EV/Sales | 3.39 |
EV/EBITDA | 9.88 |
Price/Sales | 2.57 |
Price/Book | 6.43 |
PEG ratio | 2.30 |
EPS | 7.43 |
Revenue | 15.11B |
EBITDA | 3.34B |
Income | 1.35B |
Revenue Q/Q | 2.40% |
Revenue Y/Y | 4.27% |
Profit margin | 7.57% |
Oper. margin | 12.48% |
Gross margin | 34.89% |
EBIT margin | 12.48% |
EBITDA margin | 22.12% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeIQVIA Holdings stock price history
IQVIA Holdings stock forecast
IQVIA Holdings financial statements
Average Price Target
$249.63
Potential upside: 30.39%
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 3.72B | 297M | 7.97% |
|---|---|---|---|
| Sep 2023 | 3.73B | 303M | 8.11% |
| Dec 2023 | 3.90B | 469M | 12% |
| Mar 2024 | 3.74B | 288M | 7.7% |
| Jun 2023 | 26036000000 | 20.28B | 77.92% |
|---|---|---|---|
| Sep 2023 | 25977000000 | 20.17B | 77.65% |
| Dec 2023 | 26681000000 | 20.56B | 77.09% |
| Mar 2024 | 26574000000 | 20.23B | 76.13% |
| Jun 2023 | 402M | -596M | 95M |
|---|---|---|---|
| Sep 2023 | 583M | -573M | -144M |
| Dec 2023 | 747M | -212M | -420M |
| Mar 2024 | 522M | -314M | -106M |
IQVIA Holdings alternative data
IQVIA
| 19 Feb 2023 | 58 |
|---|---|
| 26 Feb 2023 | 53 |
| 5 Mar 2023 | 55 |
| 12 Mar 2023 | 65 |
| 19 Mar 2023 | 66 |
| 26 Mar 2023 | 61 |
| 2 Apr 2023 | 66 |
| 9 Apr 2023 | 66 |
| 16 Apr 2023 | 58 |
| 23 Apr 2023 | 63 |
| 30 Apr 2023 | 60 |
| 7 May 2023 | 64 |
| 14 May 2023 | 55 |
| 21 May 2023 | 52 |
| 28 May 2023 | 56 |
| 4 Jun 2023 | 58 |
| 11 Jun 2023 | 56 |
| 18 Jun 2023 | 61 |
| 25 Jun 2023 | 60 |
| 2 Jul 2023 | 58 |
Numbers represent search interest relative to the highest point on the chart for the given region and time.
A value of 100 is the peak popularity for the term.
A value of 50 means that the term is half as popular.
A score of 0 means there was not enough data for this term.
What is job openings count?
| Aug 2023 | 3,953 |
|---|---|
| Sep 2023 | 3,517 |
| Oct 2023 | 3,421 |
| Nov 2023 | 3,274 |
| Dec 2023 | 3,231 |
| Jan 2024 | 2,357 |
| Feb 2024 | 3,246 |
| Apr 2024 | 2,384 |
| May 2024 | 2,984 |
| Jun 2024 | 2,142 |
| Jul 2024 | 2,042 |
| Dec 2024 | 2,479 |
| Aug 2023 | 87,000 |
|---|---|
| Sep 2023 | 87,000 |
| Oct 2023 | 87,000 |
| Nov 2023 | 87,000 |
| Dec 2023 | 87,000 |
| Jan 2024 | 87,000 |
| Feb 2024 | 87,000 |
| Mar 2024 | 87,000 |
| Apr 2024 | 87,000 |
| May 2024 | 87,000 |
| Jun 2024 | 87,000 |
| Jul 2024 | 87,000 |
IQVIA Holdings other data
83.35%
-1.67%
of IQV is owned by hedge funds
861
-52
162.52M
-3.50M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| May 2023 | 0 | 1 |
| Jun 2023 | 0 | 5820 |
| Sep 2023 | 0 | 27317 |
| Dec 2023 | 0 | 13117 |
| Feb 2024 | 0 | 37175 |
| Mar 2024 | 0 | 31678 |
| Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
|---|---|---|---|---|---|---|---|
Option | BOUSBIB ARI director, officer.. | Common Stock | 42,847 | $65.16 | $2,791,911 | ||
Option | BOUSBIB ARI director, officer.. | Common Stock | 42,847 | $65.16 | $2,791,911 | ||
Sale | BOUSBIB ARI director, officer.. | Common Stock | 16,261 | $250.05 | $4,066,063 | ||
Sale | BOUSBIB ARI director, officer.. | Common Stock | 16,261 | $250.05 | $4,066,063 | ||
Sale | BOUSBIB ARI director, officer.. | Common Stock | 15,417 | $251.03 | $3,870,130 | ||
Sale | BOUSBIB ARI director, officer.. | Common Stock | 15,417 | $251.03 | $3,870,130 | ||
Option | BOUSBIB ARI director, officer.. | Stock Appreciation Right | 42,847 | $65.16 | $2,791,911 | ||
Option | BOUSBIB ARI director, officer.. | Stock Appreciation Right | 42,847 | $65.16 | $2,791,911 | ||
Sale | STAUB W RICHARD officer: See Rema.. | Common Stock | 8,970 | $247.33 | $2,218,550 | ||
Sale | STAUB W RICHARD officer: See Rema.. | Common Stock | 8,970 | $247.33 | $2,218,550 |
| Quarter | Transcript |
|---|---|
| Q1 2024 2 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 14 Feb 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 1 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 1 Aug 2023 | Q2 2023 Earnings Call Transcript |
Veeva Systems: The Strong Quarter May Be A First Of Many To Come
Veeva Systems: AI And Vault CRM Are Key Long-Term Tailwinds
Why Investors Should Watch Teva Despite Regional Risks
Why AbbVie's Stock Is A Strong Buy After Q1 2025 Results
Veeva Systems: Forget The Short-Term Volatility; The Long Term Is Promising
Fortrea: Turning Around As The Activists Move In
ICON: A High Probability Of Success In The Uncertain R&D Process
IQVIA Holdings: Share Price Disconnected From Growth Outlook
Medpace: Clear Winner If China Blockade Succeeds
-
What's the price of IQVIA Holdings stock today?
One share of IQVIA Holdings stock can currently be purchased for approximately $191.44.
-
When is IQVIA Holdings's next earnings date?
Unfortunately, IQVIA Holdings's (IQV) next earnings date is currently unknown.
-
Does IQVIA Holdings pay dividends?
No, IQVIA Holdings does not pay dividends.
-
How much money does IQVIA Holdings make?
IQVIA Holdings has a market capitalization of 35.86B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 3.98% to 14.98B US dollars.
-
What is IQVIA Holdings's stock symbol?
IQVIA Holdings Inc. is traded on the NYSE under the ticker symbol "IQV".
-
What is IQVIA Holdings's primary industry?
Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.
-
How do i buy shares of IQVIA Holdings?
Shares of IQVIA Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are IQVIA Holdings's key executives?
IQVIA Holdings's management team includes the following people:
- Mr. Ari Bousbib Chairman, Pres & Chief Executive Officer(age: 64, pay: $8,760,000)
- Mr. Ronald E. Bruehlman Executive Vice President & Chief Financial Officer(age: 64, pay: $1,670,000)
- Mr. W. Richard Staub III Pres of R&D Solutions(age: 62, pay: $1,450,000)
- Mr. Eric M. Sherbet Executive Vice President, Gen. Counsel & Sec.(age: 61, pay: $1,240,000)
- Mr. Kevin C. Knightly Pres of Technology & Commercial Solutions(age: 64, pay: $1,230,000)
-
How many employees does IQVIA Holdings have?
As Jul 2024, IQVIA Holdings employs 87,000 workers.
-
When IQVIA Holdings went public?
IQVIA Holdings Inc. is publicly traded company for more then 12 years since IPO on 9 May 2013.
-
What is IQVIA Holdings's official website?
The official website for IQVIA Holdings is iqvia.com.
-
Where are IQVIA Holdings's headquarters?
IQVIA Holdings is headquartered at 4820 Emperor boulevard, Durham, NC.
-
How can i contact IQVIA Holdings?
IQVIA Holdings's mailing address is 4820 Emperor boulevard, Durham, NC and company can be reached via phone at +91 99982000.
-
What is IQVIA Holdings stock forecast & price target?
Based on 7 Wall Street analysts` predicted price targets for IQVIA Holdings in the last 12 months, the avarage price target is $249.63. The average price target represents a 30.39% change from the last price of $191.44.
IQVIA Holdings company profile:
IQVIA Holdings Inc.
iqvia.comExchange:
NYSE
Full time employees:
88,000
Industry:
Medical - Diagnostics & Research
Sector:
Healthcare
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.
4820 Emperor boulevard
Durham, NC 27703
Durham, NC 27703
CIK: 0001478242
ISIN: US46266C1053
CUSIP: 46266C105
